Efgartigimod as a novel FcRn inhibitor for autoimmune disease
Article in Neurological Sciences (April 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy
Article in JAMA Dermatology (March 2024)
Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases
Article in Frontiers in Immunology (February 2024)